Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Mayer

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Nature Biotechnology|April 15, 2014
ProteomeXchange provides globally coordinated proteomics data submission and disseminationJuan A Vizcaíno, Eric W Deutsch, Rui Wang, et al.
Frontiers in Public Health|February 1, 2021
Reduced Rate of Inpatient Hospital Admissions in 18 German University Hospitals During the COVID-19 LockdownLorenz A Kapsner, Marvin O Kampf, Susanne A Seuchter, et al.
Neurological Research and Practice|March 6, 2024
Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis, the ProVal-MS studyAntonios Bayas, Ulrich Mansmann, Begum Irmak Ön, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Nature Biotechnology|April 15, 2014
ProteomeXchange provides globally coordinated proteomics data submission and disseminationJuan A Vizcaíno, Eric W Deutsch, Rui Wang, et al.
Frontiers in Public Health|February 1, 2021
Reduced Rate of Inpatient Hospital Admissions in 18 German University Hospitals During the COVID-19 LockdownLorenz A Kapsner, Marvin O Kampf, Susanne A Seuchter, et al.
Neurological Research and Practice|March 6, 2024
Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis, the ProVal-MS studyAntonios Bayas, Ulrich Mansmann, Begum Irmak Ön, et al.
Pageof 4